Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(15 sites)
United States
The University of Alabama, Birmingham, Alabama Mount Sinai, New York, New York Christ Hospital, Cincinnati, Ohio Ohio State University, Columbus, Ohio OU Health Stephenson Cancer Center, Oklahoma City, Oklahoma